Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Show other versions (1)

AIMS: The EVOLVE FHU trial demonstrated non-inferiority of six-month late loss with two dose formulations of SYNERGY, a novel bioabsorbable polymer everolimus-eluting stent (EES) compared with the durable polymer PROMUS Element (PE) EES. The current analysis describes the six-month IVUS and clinical...

Full description

Bibliographic Details
Main Authors: Meredith, I, Verheye, S, Weissman, N, Barragan, P, Scott, D, Valdés Chávarri, M, West, N, Kelbæk, H, Whitbourn, R, Walters, D, Kubica, J, Thuesen, L, Masotti, M, Banning, A, Sjögren, I, Stables, R, Allocco, D, Dawkins, K
Format: Journal article
Language:English
Published: 2013

Similar Items